Abstract:Rationale:Since the introduction of the aldosterone-to-renin ratio (ARR) as a screening tool for primary aldosteronism (PA), there has been a marked increase in the reported prevalence of this condition among hypertensive, even normotensive, subjects. Patient concerns:But ARR as a spot blood draw for estimating a patient's aldosterone secretory status is influenced by many factors. Diagnoses:Here, we describe a series of patients with biochemically confirmed PA, whose diagnosis was delayed by the initial ARR assessment with non-suppressed renin. Interventions:Patient 1 had a history of resistant hypertension for many years and had a negative initial screening for secondary hypertension (including ARR). At the reevaluation, ARR was close to cutoff still with normal renin after strict and extended drug washout, and the further workup for PA demonstrated a unilateral aldosterone producing adenoma that was surgically removed, with subsequent complete biochemical remission and partial clinical success. Patient 2 was diagnosed with idiopathic hyperaldosteronism combined with obstructive sleep apnea syndrome, which could increase renin resulting in a negative ARR, and finally got a better treatment effect with PA-specific spironolactone, as well as continuous positive airway pressure. Patient 3 with hypokalemia as the main presentation was finally diagnosed with PA after excluding other diseases, and proceeded to laparoscopic adrenalectomy and histologically confirmed an aldosterone producing adenoma. Postoperatively, patient 3 achieved complete biochemical success without any medicine. Outcomes:The clinical status of all three patients was effectively managed, resulting in either complete resolution or notable improvement of their respective conditions. Lessons:After rigorous standardized diagnostic evaluation, there are still many reasons for ARR negative in PA, but they all basically occur in the background of normal or normal-high renin without suppression. A negative screening test result should be repeated and analyzed carefully if this is not consistent with the clinical picture. If, despite a repeatedly negative ARR, clinical suspicion remains high, we recommend consideration of further evaluation, including confirmatory tests and adrenal venous blood sampling (AVS) or even 68Ga-pentixafor PET/CT to better confirm the diagnosis and improve patient outcomes.

Screening for Primary Aldosteronism on and off Interfering Medications.

Performance of aldosterone-to-renin ratio before washout of antihypertensive drugs in screening of primary aldosteronism

Clinical Significance of Aldosterone to Renin Ratio in Screening Primary Aldosteronism

The Association Between Egfr and the Aldosterone-to-Renin Ratio and Its Effect on Screening for Primary Aldosteronism.

[Aldosterone-to-renin Ratio Threshold for Screening Primary Aldosteronism in Chinese Hypertensive Patients].

Effect of age on aldosterone/renin ratio (ARR) and comparison of screening accuracy of ARR plus elevated serum aldosterone concentration for primary aldosteronism screening in different age groups

Optimizing the aldosterone-to-renin ratio cut-off for screening primary aldosteronism based on cardiovascular risk: a collaborative study

Case Series: Primary Aldosteronism Diagnosed Despite Normal Screening Investigations: A Report of Three Cases

Challenges in screening tests of primary aldosteronism

Diagnostic Accuracy of Aldosterone and Renin Measurement by Chemiluminescence for Screening of Patients with Primary Aldosteronism

Comparing ARR Versus Suppressed PRA as Screening Tests for Primary Aldosteronism

Stroke Risks in Primary Aldosteronism with Different Treatments: A Systematic Review and Meta-Analysis

Screening for primary aldosteronism in patients with resistant hypertension

Analysis of the influencing factors for screening primary aldosteronism

Clinical significance of LC-MS/MS aldosterone in screening for primary aldosteronism

Screening parameters for diagnosing primary aldosteronism in patients with moderate to severe obstructive sleep apnea hypopnea syndrome and resistant hypertension

Clinical Characteristics of Primary Aldosteronism Screened from Chinese Patients with Hypertension: the China Primary Aldosteronism Prospective Study.

The role of confirmatory tests in the diagnosis of primary aldosteronism

Urine aldosterone and urine aldosterone-to-active-renin ratio in the diagnosis of primary aldosteronism

Steroidomics-Based Screening for Primary Aldosteronism: Impact of antihypertensive Drugs

EVALUATION AND COMPARISON OF DIAGNOSTIC EFFICACY OF INDICATORS TO SCREENING FOR PRIMARY ALDOSTERONISM BEFORE ENDOCRINE PATHWAY